Novo Nordisk
-
healthHow a 1922 Rescue Mission Explains Ozempic’s $969 US vs. €59 German Price
The identical semaglutide pen costs sixteen times more in the US than in Germany. The price gap traces back to a Canadian discovery, a Danish foundation, and America's unique pharmacy-benefit system.
-
healthFrom Lizard Venom to National Phenomenon: How GLP-1 Drugs Reached One in Eight Americans
A Bronx endocrinologist’s discovery in Gila monster saliva, initially rejected by the government, spawned a class of drugs now used by roughly one in eight U.S. adults for weight loss and diabetes.
-
healthNovo Nordisk Opens Affordable Access to Semaglutide Through Medicare GLP-1 Bridge
Novo Nordisk launches a nationwide Medicare program offering its FDA-approved semaglutide injection and pill for a fixed $50 monthly copay through 2027.
-
healthHealth Canada Greenlights First Generic Semaglutide Injection for Weight Loss
Canada approves Apotex's Svemia, a generic Wegovy alternative, expanding affordable chronic weight management options following a reduced-calorie diet and exercise.
-
healthMedicare Launches Pilot Program for Weight-Loss Drugs Wegovy, Zepbound
A new Medicare bridge program will cover popular weight-loss medications like Wegovy and Zepbound for eligible older adults starting July 1st, with a $50 monthly copay.
-
healthUK Approves First Daily Oral GLP-1 Semaglutide for Obesity Treatment
Novo Nordisk secures UK approval for daily oral semaglutide, offering a non-injectable alternative for obesity management with significant weight loss results in clinical trials.
-
healthBoehringer's Obesity Drug Shows Promising Weight Loss, Flagging Tolerability Concerns
Boehringer Ingelheim releases detailed phase 3 obesity drug data: 16.6% weight loss, significant liver fat reduction, but tolerability issues spark investor sell-off.
-
healthSemaglutide Boosts Quality of Life in Diabetes and Kidney Disease Patients
New FLOW trial data shows semaglutide improves daily functioning and well-being in adults with type 2 diabetes and chronic kidney disease.